XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Impact of adoption of Accounting Standards Update (“ASU”) 2016-13
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Impact of adoption of Accounting Standards Update (“ASU”) 2016-13
Accumulated Other Comprehensive Income/(Loss), net of tax
Beginning balance (in shares) at Dec. 31, 2022     2,583,619        
Beginning balance at Dec. 31, 2022 $ 97,705 $ (1,149) $ 26 $ 28,004 $ 70,792 $ (1,149) $ (1,117)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 5,059       5,059    
Other comprehensive (loss) income, net of tax 23           23
Share-based compensation 279     279      
Restricted stock awards issued (in shares)     8,850        
Cash dividends paid on common stock (936)       (936)    
Common stock repurchased (in shares)     (31,681)        
Common stock repurchased (1,170)   $ (1) (326) (843)    
Common stock surrendered (in shares)     (4,750)        
Common stock surrendered (190)     (190)      
Restricted shares forfeited (in shares)     (425)        
Common stock options exercised (in shares)     17,610        
Common stock options exercised 303     303      
Ending balance (in shares) at Jun. 30, 2023     2,573,223        
Ending balance at Jun. 30, 2023 99,924   $ 25 28,070 72,923 (1,149) (1,094)
Beginning balance (in shares) at Mar. 31, 2023     2,601,443        
Beginning balance at Mar. 31, 2023 98,605   $ 26 28,251 71,362   (1,034)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 2,892       2,892    
Other comprehensive (loss) income, net of tax (60)           (60)
Share-based compensation 87     87      
Cash dividends paid on common stock (494)       (494)    
Common stock repurchased (in shares)     (31,477)        
Common stock repurchased (1,162)   $ (1) (324) (837)    
Common stock options exercised (in shares)     3,257        
Common stock options exercised 56     56      
Ending balance (in shares) at Jun. 30, 2023     2,573,223        
Ending balance at Jun. 30, 2023 $ 99,924   $ 25 28,070 72,923 (1,149) (1,094)
Beginning balance (in shares) at Dec. 31, 2023 2,549,427   2,549,427        
Beginning balance at Dec. 31, 2023 $ 100,654   $ 25 27,990 73,627   (988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 1,564       1,564    
Other comprehensive (loss) income, net of tax (61)           (61)
Share-based compensation 193     193      
Restricted stock awards issued (in shares)     8,048        
Cash dividends paid on common stock (972)       (972)    
Common stock repurchased (in shares)     (1,626)        
Common stock repurchased (64)     (18) (46)    
Common stock options exercised (in shares)     1,435        
Common stock options exercised $ 33     33      
Ending balance (in shares) at Jun. 30, 2024 2,557,284   2,557,284        
Ending balance at Jun. 30, 2024 $ 101,347   $ 25 28,198 74,173 0 (1,049)
Beginning balance (in shares) at Mar. 31, 2024     2,558,546        
Beginning balance at Mar. 31, 2024 100,992   $ 25 28,110 73,907   (1,050)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 795       795    
Other comprehensive (loss) income, net of tax 1           1
Share-based compensation 97     97      
Cash dividends paid on common stock (486)       (486)    
Common stock repurchased (in shares)     (1,462)        
Common stock repurchased (59)     (16) (43)    
Common stock options exercised (in shares)     200        
Common stock options exercised $ 7     7      
Ending balance (in shares) at Jun. 30, 2024 2,557,284   2,557,284        
Ending balance at Jun. 30, 2024 $ 101,347   $ 25 $ 28,198 $ 74,173 $ 0 $ (1,049)